154 related articles for article (PubMed ID: 17333484)
41. Discovery of small-molecule inhibitors of tyrosinase.
Germanas JP; Wang S; Miner A; Hao W; Ready JM
Bioorg Med Chem Lett; 2007 Dec; 17(24):6871-5. PubMed ID: 17964155
[TBL] [Abstract][Full Text] [Related]
42. Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors.
Zhou Z; Zhuo J; Yan S; Ma L
Bioorg Med Chem; 2013 Apr; 21(7):2156-62. PubMed ID: 23391365
[TBL] [Abstract][Full Text] [Related]
43. Tyrosinase inhibitory activities of cinnamic acid analogues.
Takahashi T; Miyazawa M
Pharmazie; 2010 Dec; 65(12):913-8. PubMed ID: 21284262
[TBL] [Abstract][Full Text] [Related]
44. Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors.
Radhakrishnan S; Shimmon R; Conn C; Baker A
Bioorg Med Chem Lett; 2015 Oct; 25(19):4085-91. PubMed ID: 26318997
[TBL] [Abstract][Full Text] [Related]
45. Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications.
Mendes E; Perry Mde J; Francisco AP
Expert Opin Drug Discov; 2014 May; 9(5):533-54. PubMed ID: 24708040
[TBL] [Abstract][Full Text] [Related]
46. Physicochemical characters of a tyrosinase inhibitor produced by Streptomyces roseolilacinus NBRC 12815.
Nakashima T; Anzai K; Kuwahara N; Komaki H; Miyadoh S; Harayama S; Tianero MD; Tanaka J; Kanamoto A; Ando K
Biol Pharm Bull; 2009 May; 32(5):832-6. PubMed ID: 19420750
[TBL] [Abstract][Full Text] [Related]
47. Tyrosinase inhibitors: a patent review (2011-2015).
Ullah S; Son S; Yun HY; Kim DH; Chun P; Moon HR
Expert Opin Ther Pat; 2016; 26(3):347-62. PubMed ID: 26815044
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of bergenin analogues as mushroom tyrosinase inhibitors.
Kashima Y; Miyazawa M
Arch Pharm Res; 2012 Sep; 35(9):1533-41. PubMed ID: 23054709
[TBL] [Abstract][Full Text] [Related]
49. Benzyl benzoates: New phlorizin analogs as mushroom tyrosinase inhibitors.
Fang Y; Chen Y; Feng G; Ma L
Bioorg Med Chem; 2011 Feb; 19(3):1167-71. PubMed ID: 21256757
[TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis and Biological Evaluation of Oxindole-Based Chalcones as Small-Molecule Inhibitors of Melanogenic Tyrosinase.
Suthar SK; Bansal S; Narkhede N; Guleria M; Alex AT; Joseph A
Chem Pharm Bull (Tokyo); 2017; 65(9):833-839. PubMed ID: 28867710
[TBL] [Abstract][Full Text] [Related]
51. N-Benzylbenzamides: a new class of potent tyrosinase inhibitors.
Cho SJ; Roh JS; Sun WS; Kim SH; Park KD
Bioorg Med Chem Lett; 2006 May; 16(10):2682-4. PubMed ID: 16513349
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of novel 4-hydroxybenzaldehyde derivatives as tyrosinase inhibitors.
Yi W; Cao R; Peng W; Wen H; Yan Q; Zhou B; Ma L; Song H
Eur J Med Chem; 2010 Feb; 45(2):639-46. PubMed ID: 19932528
[TBL] [Abstract][Full Text] [Related]
53. Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.
Ha YM; Park YJ; Kim JA; Park D; Park JY; Lee HJ; Lee JY; Moon HR; Chung HY
Eur J Med Chem; 2012 Mar; 49():245-52. PubMed ID: 22301213
[TBL] [Abstract][Full Text] [Related]
54. A rational workflow for sequential virtual screening of chemical libraries on searching for new tyrosinase inhibitors.
Le-Thi-Thu H; Casanola-Martín GM; Marrero-Ponce Y; Rescigno A; Abad C; Khan MT
Curr Top Med Chem; 2014; 14(12):1473-85. PubMed ID: 24853562
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations.
Shimizu K; Kondo R; Sakai K
Planta Med; 2000 Feb; 66(1):11-5. PubMed ID: 10705726
[TBL] [Abstract][Full Text] [Related]
56. Structure-based modification of 3-/4-aminoacetophenones giving a profound change of activity on tyrosinase: from potent activators to highly efficient inhibitors.
You A; Zhou J; Song S; Zhu G; Song H; Yi W
Eur J Med Chem; 2015 Mar; 93():255-62. PubMed ID: 25686594
[TBL] [Abstract][Full Text] [Related]
57. Non-stochastic and stochastic linear indices of the 'molecular pseudograph's atom adjacency matrix': application to 'in silico' studies for the rational discovery of new antimalarial compounds.
Marrero-Ponce Y; Montero-Torres A; Zaldivar CR; Veitía MI; Peréz MM; Sánchez RN
Bioorg Med Chem; 2005 Feb; 13(4):1293-304. PubMed ID: 15670938
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of dihydropyrimidin-(2H)-one analogues and rhodanine derivatives as tyrosinase inhibitors.
Liu J; Wu F; Chen L; Hu J; Zhao L; Chen C; Peng L
Bioorg Med Chem Lett; 2011 Apr; 21(8):2376-9. PubMed ID: 21411319
[TBL] [Abstract][Full Text] [Related]
59. TOMOCOMD-CARDD, a novel approach for computer-aided 'rational' drug design: I. Theoretical and experimental assessment of a promising method for computational screening and in silico design of new anthelmintic compounds.
Marrero-Ponce Y; Castillo-Garit JA; Olazabal E; Serrano HS; Morales A; Castañedo N; Ibarra-Velarde F; Huesca-Guillen A; Jorge E; del Valle A; Torrens F; Castro EA
J Comput Aided Mol Des; 2004 Oct; 18(10):615-34. PubMed ID: 15849993
[TBL] [Abstract][Full Text] [Related]
60. Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation.
Ha YM; Kim JA; Park YJ; Park D; Kim JM; Chung KW; Lee EK; Park JY; Lee JY; Lee HJ; Yoon JH; Moon HR; Chung HY
Biochim Biophys Acta; 2011 Jun; 1810(6):612-9. PubMed ID: 21397665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
